Alentis Therapeutics
Drug DiscoveryWebsite
Operator of a clinical-stage biopharmaceutical company intended to offer various treatments for cancer and fibrotic diseases. The company develops innovative therapies for the treatment of cancer and ...
Valuation
$0
Share Price
N/A
Total Raised
$362.5M
Last Round
Later Stage VC (Series D)
Nov 2024
Latest Funding Round
Later Stage VC (Series D)
Nov 11, 2024
$181.4M
raised
Investors
+21 other investors